Jennifer Jarrett is the Chief Operating Officer at Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With a robust background in the biotechnology and pharmaceutical sectors, Jarrett has been instrumental in steering Arcus Biosciences through its growth phases and into the clinical trial stages of its drug development programs. Prior to joining Arcus, she held significant leadership roles at Genentech and Gilead Sciences, where she honed her expertise in operational management, strategic planning, and product development. At Arcus Biosciences, Jarrett oversees the company's operational strategy, ensuring that the organization's resources are effectively aligned with its mission to advance cancer treatment. Her role encompasses managing the company's clinical operations, supply chain, and quality assurance, all critical components in the successful development and eventual commercialization of new therapies. Under her leadership, Arcus has made significant strides in advancing its pipeline of immuno-oncology agents, including notable progress in clinical trials that are pivotal for the company's future. Jarrett's achievements extend beyond her operational roles; she is recognized for her contributions to the biotech industry as a whole. Her strategic vision and operational acumen have been pivotal in forging key partnerships and collaborations that have enhanced Arcus Biosciences' research capabilities and market position. Her dedication to improving patient outcomes through innovative science continues to drive the company's mission forward, cementing her reputation as a leader in the field of biopharmaceuticals.